GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Short Interest

ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition II Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of ARYA Sciences Acquisition II's Short Interest

For the Shell Companies subindustry, ARYA Sciences Acquisition II's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ARYA Sciences Acquisition II's Short Interest Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, ARYA Sciences Acquisition II's Short Interest distribution charts can be found below:

* The bar in red indicates where ARYA Sciences Acquisition II's Short Interest falls into.


ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Short Interest
Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp II is a blank check company.
Executives
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc director 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Life Sciences Master Fund Ltd director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Adam Leo Stone director, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Ii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Jake Bauer director C/O MYOKARDIA, INC., 333 ALLERTON AVENUE, SOUTH SAN FRANCISCO CA 94080
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016
Chad M Robins director C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102